Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

PNAS 99 (23): 14976-14981

Copyright © 2002 by the National Academy of Sciences.


BIOLOGICAL SCIENCES / GENETICS

Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1

Marcel Tuynder*, Laurent Susini*, Sylvie Prieur, Stéphanie Besse, Giusy Fiucci, Robert Amson, and Adam Telerman{dagger}

Molecular Engines Laboratories, 20 Rue Bouvier, 75011 Paris, France

Accepted for publication September 6, 2002.

Received for publication June 19, 2002.

Abstract: Tumor reversion is the process by which some cancer cells lose their malignant phenotype. This study was aimed at defining some of the molecular and phenotypic properties of this process. Biological models of tumor reversion were isolated from human leukemia and breast cancer cell lines by using the H-1 parvovirus as a selective agent. Differential gene expression analysis was performed between the parental malignant cells and their revertants or alternatively between these parental cells and their SIAH-1 transfectant counterparts. These SIAH-1 transfectants have a suppressed malignant phenotype and were used as a control for a viral-free system. Two hundred sixty-three genes were found to be either activated or inhibited during the reversion process, as confirmed by Northern blot analysis or quantitative PCR. Of these, 32% were differentially expressed in all systems, irrespective of whether parvovirus-selected, SIAH-1 overexpressing, or p53 mutant or wild-type cell lines were used, suggesting the existence of a universal mechanism underlying tumor reversion. Translationally Controlled Tumor Protein (tpt1/TCTP) has the strongest differential expression, down-regulated in the reversion of U937- and SIAH-1-overexpressing cells. Inhibition of TCTP expression by anti-sense cDNA or small interfering RNA molecules results in suppression of the malignant phenotype and in cellular reorganization, similar to the effect of SIAH-1. Hence, tumor reversion can be defined at the molecular level, not just as the reversal of malignant transformation, but as a biological process in its own right involving a cellular reprogramming mechanism, overriding genetic changes in cancer, by triggering an alternative pathway leading to suppression of tumorigenicity.


* M.T. and L.S. contributed equally to this work.

{dagger} To whom correspondence should be addressed. E-mail: atelerman{at}molecular-engines.com.

Communicated by Georges Charpak, European Organization for Nuclear Research, Geneva, Switzerland

Data deposition: The sequences reported in this paper have been deposited in the GenBank database (accession nos. BQ739779BQ739784).


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced {beta}-catenin/TCF-4 transcription.
X. Gu, L. Yao, G. Ma, L. Cui, Y. Li, W. Liang, B. Zhao, and K. Li (2014)
Neuro Oncology 16, 217-227
   Abstract »    Full Text »    PDF »
Siah: A Promising Anticancer Target.
C. S. F. Wong and A. Moller (2013)
Cancer Res. 73, 2400-2406
   Abstract »    Full Text »    PDF »
STEAP Proteins: From Structure to Applications in Cancer Therapy.
I. M. Gomes, C. J. Maia, and C. R. Santos (2012)
Mol. Cancer Res. 10, 573-587
   Abstract »    Full Text »    PDF »
A Novel TCTP Gene From the Crustacean Eriocheir sinensis: Possible Role Involving Metallic Cu2+ Stress.
Q. Wang, D.-A. Fang, W.-W. Li, J. Wang, and H. Jiang (2011)
Biol. Bull. 221, 290-299
   Abstract »    Full Text »    PDF »
Physical and Functional Antagonism between Tumor Suppressor Protein p53 and Fortilin, an Anti-apoptotic Protein.
Y. Chen, T. Fujita, D. Zhang, H. Doan, D. Pinkaew, Z. Liu, J. Wu, Y. Koide, A. Chiu, C. C.-J. Lin, et al. (2011)
J. Biol. Chem. 286, 32575-32585
   Abstract »    Full Text »    PDF »
Critical Roles of Translationally Controlled Tumor Protein in the Homeostasis and TCR-Mediated Proliferation of Peripheral T Cells.
P.-S. Wu, C.-Y. Yang, J. J.-Y. Yen, C.-H. Chou, S. H. Chen, C.-K. L. Wang, Y.-G. Lai, N.-S. Liao, and H.-F. Yang-Yen (2009)
J. Immunol. 183, 2373-2381
   Abstract »    Full Text »    PDF »
Complex relationship between TCTP, microtubules and actin microfilaments regulates cell shape in normal and cancer cells.
F. Bazile, A. Pascal, I. Arnal, C. Le Clainche, F. Chesnel, and J. Z. Kubiak (2009)
Carcinogenesis 30, 555-565
   Abstract »    Full Text »    PDF »
Characterization of TCTP, the Translationally Controlled Tumor Protein, from Arabidopsis thaliana.
O. Berkowitz, R. Jost, S. Pollmann, and J. Masle (2008)
PLANT CELL 20, 3430-3447
   Abstract »    Full Text »    PDF »
A Knockout Mouse Approach Reveals that TCTP Functions as an Essential Factor for Cell Proliferation and Survival in a Tissue- or Cell Type-specific Manner.
S. H. Chen, P.-S. Wu, C.-H. Chou, Y.-T. Yan, H. Liu, S.-Y. Weng, and H.-F. Yang-Yen (2007)
Mol. Biol. Cell 18, 2525-2532
   Abstract »    Full Text »    PDF »
Siah1 Interacts with the Scaffold Protein POSH to Promote JNK Activation and Apoptosis.
Z. Xu, A. Sproul, W. Wang, N. Kukekov, and L. A. Greene (2006)
J. Biol. Chem. 281, 303-312
   Abstract »    Full Text »    PDF »
The Translationally Controlled Tumor Protein Is a Novel Calcium Binding Protein of the Human Placenta and Regulates Calcium Handling in Trophoblast Cells.
F. Arcuri, S. Papa, A. Meini, A. Carducci, R. Romagnoli, L. Bianchi, M. G. Riparbelli, J.-C. Sanchez, M. Palmi, P. Tosi, et al. (2005)
Biol Reprod 73, 745-751
   Abstract »    Full Text »    PDF »
Stabilization and Enhancement of the Antiapoptotic Activity of Mcl-1 by TCTP.
H. Liu, H.-W. Peng, Y.-S. Cheng, H. S. Yuan, and H.-F. Yang-Yen (2005)
Mol. Cell. Biol. 25, 3117-3126
   Abstract »    Full Text »    PDF »
TSAP6 Facilitates the Secretion of Translationally Controlled Tumor Protein/Histamine-releasing Factor via a Nonclassical Pathway.
N. Amzallag, B. J. Passer, D. Allanic, E. Segura, C. Thery, B. Goud, R. Amson, and A. Telerman (2004)
J. Biol. Chem. 279, 46104-46112
   Abstract »    Full Text »    PDF »
Translationally controlled tumor protein is a target of tumor reversion.
M. Tuynder, G. Fiucci, S. Prieur, A. Lespagnol, A. Geant, S. Beaucourt, D. Duflaut, S. Besse, L. Susini, J. Cavarelli, et al. (2004)
PNAS 101, 15364-15369
   Abstract »    Full Text »    PDF »
Antiapoptotic Protein Partners Fortilin and MCL1 Independently Protect Cells from 5-Fluorouracil-induced Cytotoxicity.
P. Graidist, A. Phongdara, and K. Fujise (2004)
J. Biol. Chem. 279, 40868-40875
   Abstract »    Full Text »    PDF »
SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasome.
J. P. Venables, C. Dalgliesh, M. P. Paronetto, L. Skitt, J. K. Thornton, P. T. Saunders, C. Sette, K. T. Jones, and D. J. Elliott (2004)
Hum. Mol. Genet. 13, 1525-1534
   Abstract »    Full Text »    PDF »
Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter.
G. Fiucci, S. Beaucourt, D. Duflaut, A. Lespagnol, P. Stumptner-Cuvelette, A. Geant, G. Buchwalter, M. Tuynder, L. Susini, J.-M. Lassalle, et al. (2004)
PNAS 101, 3510-3515
   Abstract »    Full Text »    PDF »
Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A.
C. Cans, B. J. Passer, V. Shalak, V. Nancy-Portebois, V. Crible, N. Amzallag, D. Allanic, R. Tufino, M. Argentini, D. Moras, et al. (2003)
PNAS 100, 13892-13897
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882